Want to join the conversation?
$WAT 2Q15 Q&A: Willoughby of Cleveland had a question regarding pharma demand. Douglas replied that growth is not coming from classical big pharma accounts, which were low single-digits to flat. Most of growth was coming from specialty pharma, generics, big and small biotech accounts, most of which were new volume-based initiatives.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!